Claude C. Bernard

Building 75, Wellington Rd
Clayton, VIC 3168, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Altered expression of miR-29a-3p and miR-34a-5p by specific inhibition of GSK3β in the MPP+ treated SH-SY5Y Parkinson's model.

Altered expression of miR-29a-3p and miR-34a-5p by specific inhibition of GSK3β in the MPP+ treated SH-SY5Y Parkinson's model.

Journal: Non-coding RNA research

Published: July 19, 2021

Exploiting the preferential phagocytic uptake of nanoparticle-antigen conjugates for the effective treatment of autoimmunity.

Exploiting the preferential phagocytic uptake of nanoparticle-antigen conjugates for the effective treatment of autoimmunity.

Journal: Nanomedicine : nanotechnology, biology, and medicine

Published: February 28, 2021

TGFβ and Wnt Signaling Pathways Cooperatively Enhance Early Dopaminergic Differentiation of the Unrestricted Somatic Stem Cells.

TGFβ and Wnt Signaling Pathways Cooperatively Enhance Early Dopaminergic Differentiation of the Unrestricted Somatic Stem Cells.

Journal: Journal of molecular neuroscience : MN

Published: November 09, 2019

Therapeutic Potential of Ponesimod Alone and in Combination with Dimethyl Fumarate in Experimental Models of Multiple Sclerosis.

Therapeutic Potential of Ponesimod Alone and in Combination with Dimethyl Fumarate in Experimental Models of Multiple Sclerosis.

Journal: Innovations in clinical neuroscience

Published: June 20, 2019

Functional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease.

Functional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: September 09, 2018

Safety of the use of anti-IL17A treatment in a patient with certolizumab-induced sarcoidosis.

Safety of the use of anti-IL17A treatment in a patient with certolizumab-induced sarcoidosis.

Journal: Clinical and experimental rheumatology

Published: August 12, 2018

Redirecting adult mesenchymal stromal cells to the brain: a new approach for treating CNS autoimmunity and neuroinflammation?

Redirecting adult mesenchymal stromal cells to the brain: a new approach for treating CNS autoimmunity and neuroinflammation?

Journal: Immunology and cell biology

Published: December 20, 2017

Essential role for CCR6 in certain inflammatory diseases demonstrated using specific antagonist and knockin mice.

Essential role for CCR6 in certain inflammatory diseases demonstrated using specific antagonist and knockin mice.

Journal: JCI insight

Published: May 02, 2017

Sheep pox in Tunisia: Current status and perspectives.

Sheep pox in Tunisia: Current status and perspectives.

Journal: Transboundary and emerging diseases

Published: March 22, 2017

Altered expression of IGF-I system in neurons of the inflamed spinal cord during acute experimental autoimmune encephalomyelitis.

Altered expression of IGF-I system in neurons of the inflamed spinal cord during acute experimental autoimmune encephalomyelitis.

Journal: The Journal of comparative neurology

Published: November 30, 2016

B cell-derived transforming growth factor-β1 expression limits the induction phase of autoimmune neuroinflammation.

B cell-derived transforming growth factor-β1 expression limits the induction phase of autoimmune neuroinflammation.

Journal: Scientific reports

Published: June 20, 2016

Treatment of spontaneous EAE by laquinimod reduces Tfh, B cell aggregates, and disease progression.

Treatment of spontaneous EAE by laquinimod reduces Tfh, B cell aggregates, and disease progression.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: June 06, 2016

Showing 1-12 of 47

Last Updated: 09/26/2026